Create Free Account

By creating account you will get access to hot stocks & personalised emails

Nanosonics Ltd

Healthcare AU NAN

2.84AUD
0.01(0.35%)

Last update at 2024-05-02T06:10:00Z

Day Range

2.822.88
LowHigh

52 Week Range

2.595.63
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax 21.60M 1.58M 10.98M 12.46M 16.83M
Minority interest - - - - -
Net income 19.88M 3.74M 8.58M 10.14M 13.60M
Selling general administrative 23.70M 20.28M 16.00M 12.96M 10.72M
Selling and marketing expenses 60.95M 47.88M 37.56M 34.66M 27.09M
Gross profit 132.17M 91.31M 79.14M 76.19M 63.08M
Reconciled depreciation 7.14M 5.73M 4.43M 3.89M 2.14M
Ebit 22.37M 2.13M 11.32M 12.80M 17.06M
Ebitda 29.50M 7.86M 15.75M 16.70M 19.20M
Depreciation and amortization 7.14M 5.73M 4.43M 3.89M 2.14M
Non operating income net other - - - - -
Operating income 17.79M 1.84M 9.78M 12.34M 17.06M
Other operating expenses 146.36M 118.54M 92.32M 88.38M 72.83M
Interest expense 0.77M 0.56M 0.34M 0.34M 0.24M
Tax provision 1.71M -2.16400M 2.41M 2.32M 3.23M
Interest income 2.39M 0.35M 0.22M 0.79M 1.33M
Net interest income 1.96M -0.20400M 0.22M -0.34400M 1.33M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 1.71M -2.16400M 2.41M 2.32M 3.23M
Total revenue 167.51M 119.73M 101.83M 100.73M 84.58M
Total operating expenses 121.30M 96.25M 75.19M 67.07M 51.32M
Cost of revenue 35.35M 28.41M 22.70M 24.54M 21.51M
Total other income expense net 1.64M 0.99M 2.38M -1.33200M -0.22900M
Discontinued operations - - - - -
Net income from continuing ops 19.88M 3.74M 8.58M 10.14M 13.60M
Net income applicable to common shares 19.88M 3.74M 8.58M 10.14M 13.60M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 219.92M 187.67M 162.30M 147.07M 129.52M
Intangible assets 0.10M 0.22M 0.28M 0.49M 0.80M
Earning assets - - - - -
Other current assets 0.39M 0.24M 0.17M 0.23M 0.28M
Total liab 56.06M 48.98M 26.74M 22.84M 19.44M
Total stockholder equity 163.86M 138.69M 135.57M 124.23M 110.08M
Deferred long term liab - 0.21M 0.13M 0.16M 0.21M
Other current liab 18.59M 16.96M 12.46M 8.65M 8.28M
Common stock 114.21M 113.86M 113.54M 113.18M 112.71M
Capital stock 114.21M 113.86M 113.54M 113.18M 112.71M
Retained earnings 24.74M 4.86M 1.12M -7.46100M -17.45000M
Other liab - 10.66M 6.18M 3.44M 3.40M
Good will - - - - -
Other assets 15.36M 13.62M 10.38M 12.42M 13.38M
Cash 112.16M 94.51M 96.03M 91.78M 72.18M
Cash and equivalents 1.84M 2.09M 4.12M 6.95M 1.05M
Total current liabilities 33.03M 29.16M 19.54M 18.02M 15.96M
Current deferred revenue 7.80M 6.90M 3.55M 4.75M 4.01M
Net debt -101.43900M -82.80000M -93.53600M -89.17200M -71.65900M
Short term debt 2.88M 2.55M 1.48M 1.24M 0.45M
Short long term debt - - - 0.08M -
Short long term debt total 10.72M 11.71M 2.49M 2.61M 0.52M
Other stockholder equity -138.95300M -118.71400M -114.65600M -105.71600M 14.82M
Property plant equipment 22.50M 22.58M 9.33M 9.62M 6.73M
Total current assets 181.62M 151.25M 142.31M 124.55M 108.61M
Long term investments - - - - -
Net tangible assets - 138.47M 135.29M 123.74M 109.28M
Short term investments 88.48M 72.75M 73.00M 73.50M 59.50M
Net receivables 38.75M 28.39M 28.36M 16.91M 19.70M
Long term debt - - - - 0.08M
Inventory 25.49M 22.61M 11.87M 11.84M 14.02M
Accounts payable 3.76M 2.74M 2.05M 3.38M 3.23M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 24.91M 19.98M 20.91M 18.51M 14.82M
Additional paid in capital - - - - -
Common stock total equity - - - 113.18M 112.71M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.41M 0.28M 0.20M 0.21M 0.25M
Deferred long term asset charges - - - - -
Non current assets total 38.30M 36.42M 19.99M 22.52M 20.91M
Capital lease obligations 10.72M 11.71M 2.49M 2.53M 0.52M
Long term debt total 7.84M 9.16M 1.01M 1.37M 0.08M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -3.54100M -6.90200M -1.38100M -1.93600M -2.20100M
Change to liabilities 0.00000M 5.42M 1.77M 1.90M 4.49M
Total cashflows from investing activities -3.54100M -6.90200M -1.38100M -1.93600M -2.20100M
Net borrowings - -2.03500M -1.29800M -1.66700M -0.42500M
Total cash from financing activities -2.71200M -1.97300M -1.03400M -1.31300M -0.46100M
Change to operating activities - 1.14M 0.16M -2.86300M -0.68200M
Net income 19.88M 3.74M 8.58M 10.14M 13.60M
Change in cash 17.65M -1.51500M 4.25M 19.60M 2.75M
Begin period cash flow 94.51M 96.03M 91.78M 72.18M 69.43M
End period cash flow 112.16M 94.51M 96.03M 91.78M 72.18M
Total cash from operating activities 23.31M 6.70M 7.32M 22.81M 4.83M
Issuance of capital stock 0.36M 0.32M 0.36M 0.46M -
Depreciation 7.01M 5.48M 4.08M 3.53M 2.14M
Other cashflows from investing activities 0.03M 0.06M -0.01000M -0.01000M 0.03M
Dividends paid - - - - -
Change to inventory -3.01200M -10.74500M -1.51000M 0.45M -6.67100M
Change to account receivables -8.99800M 4.22M -10.90300M 4.88M -10.90900M
Sale purchase of stock 0.36M 0.32M 0.36M 0.46M 0.00000M
Other cashflows from financing activities -3.06800M -2.28900M -1.31900M -1.33200M -0.50000M
Change to netincome - -2.81700M 4.79M 4.41M 2.85M
Capital expenditures 3.57M 6.97M 1.37M 1.94M 2.23M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -12.01000M -6.52100M -12.41300M 5.33M 1.55M
Stock based compensation 5.46M 2.82M 2.57M 1.87M -
Other non cash items -3.57600M -2.53100M -5.34100M 9.15M -15.74200M
Free cash flow 19.74M -0.27100M 5.95M 20.88M 2.59M

Fundamentals

  • Previous Close 2.83
  • Market Cap860.46M
  • Volume328688
  • P/E Ratio56.80
  • Dividend Yield-%
  • EBITDA13.61M
  • Revenue TTM164.07M
  • Revenue Per Share TTM0.54
  • Gross Profit TTM 91.91M
  • Diluted EPS TTM0.05

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
NAN
Nanosonics Ltd		 0.01 0.35% 2.84 56.80 67.11 5.32 4.97 4.62 32.66
RMD
Resmed Inc DRC		 0.21 0.64% 32.96 33.29 23.87 9.54 6.24 9.91 31.23
FPH
Fisher & Paykel Healthcare Corporation Limited		 -0.05 0.20% 25.45 62.07 44.84 8.32 8.72 8.36 30.31
ANN
Ansell Ltd		 -0.13 0.52% 25.04 19.87 11.44 2.31 1.54 2.63 18.75
TRJ
Trajan Group Holdings Ltd		 -0.02 1.94% 1.01 - 45.45 1.22 1.55 1.53 28.06

Reports Covered

Stock Research & News

View All

Profile

Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories, as well as research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; Nanosonics AuditPro, an infection control workflow compliance management; Trophon EPR for mitigating the risk of exposure to toxic chemicals; and CORIS, an instrument reprocessing product platform. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.

Nanosonics Ltd

Building A, Macquarie Park, NSW, Australia, 2113

Key Executives

Name Title Year Born
Mr. Michael C. Kavanagh BSc, M.B.A. CEO, Pres, MD & Exec. Director NA
Mr. McGregor Grant BEc, C.A., CA, FCIS, GAICD CFO & Company Sec. NA
Mr. Rod Lopez M.B.A. Chief Operating Officer NA
Dr. Steven Farrugia BE, Ph.D. Chief Technology Officer NA
Mr. David N. Morris Chief Strategy Officer & Regional Pres Asia Pacific NA
Matthew Carbines B.Com., L.L.B. Gen. Counsel NA
Mr. Matthew Lipscombe B.E., B.Sc., M.B.A. Chief Marketing Officer NA
Ms. Jodi Sampson Chief People & Culture Officer NA
Mr. Vincent Wang Head of Global Customer Support & Technical Services NA
Mr. Keith Koby Sr. VP of Sales - North America NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Our Company

Useful Links

Contact Us

Market Research

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.